Kymera Therapeutics, Inc.
KYMR
$61.00
$1.111.85%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/12/2025
-
MarketBeat
11/7/2025
-
Simply Wall St
11/6/2025
-
TipRanks Financial Blog
11/6/2025
-
The Fly
11/6/2025
-
MarketBeat
11/5/2025
-
GuruFocus
11/5/2025
-
Ticker Report
11/5/2025
-
GuruFocus
11/5/2025
-
MarketBeat
11/5/2025
-
TipRanks Financial Blog
11/5/2025
-
Benzinga
11/5/2025
-
Tickeron - Stocks
11/5/2025
-
TipRanks Financial Blog
11/5/2025
-
The Fly
11/5/2025
-
The Fly
11/5/2025
-
GuruFocus
11/5/2025
-
TipRanks Financial Blog
11/5/2025
-
Simply Wall St
11/4/2025
-
SeekingAlpha
11/4/2025
-
Seeking Alpha: Transcripts
11/4/2025
-
SeekingAlpha
11/4/2025
-
The Fly
11/4/2025
-
TipRanks Financial Blog
11/4/2025
-
The Fly
11/4/2025
-
Nasdaq News: Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 285 5300
Address
500 North Beacon Street
Watertown, MA 02472
Watertown, MA 02472
Country
Year Founded
Business Description
Sector
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by...
more